# Biomarker for Morquio Disease (BioMorquio)

> **NCT01457456** · — · WITHDRAWN · sponsor: **CENTOGENE GmbH Rostock**

## Conditions studied

- Morquio Syndrome
- Accumulation of Mucopolysaccharides
- Morquio Syndrome A
- Morquio B Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01457456
- **Lead sponsor:** CENTOGENE GmbH Rostock
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-08-20
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Transition to BioMetabol
- **Last updated:** 2023-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01457456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01457456, "Biomarker for Morquio Disease (BioMorquio)". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT01457456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*